Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021


HomeACQUISITIONS and MERGERSAmerican College of Cardiology Acquires MedAxiom

American College of Cardiology Acquires MedAxiom

New ACC Company Provides CV Service Line Solutions for Transforming Health Care

February 4, 2019: Today the American College of Cardiology Foundation announced they have acquired MedAxiom, a cardiovascular membership, services and consulting firm, adding the company’s recognized leadership in cardiovascular operations, performance improvement, and business acumen to ACC’s world class science, education, registry, quality improvement and advocacy work.

Through this acquisition, the ACC will expand its offerings as the professional home for the entire cardiovascular team to include services and education in non-clinical domains such as interpersonal and organizational leadership, strategic design, operational and performance management, and improvement and technological infrastructure.

“The expansion of advanced technology and the renewed focus on value are radically remaking what it means to be a good clinician in the 21 Century,” said ACC CEO Tim Attebery, DSc, MBA, FACHE. “We must embrace these changes and ensure that cardiovascular care team members are empowered to thrive in this new world. By welcoming MedAxiom into the ACC family, clinicians, practices, health systems and hospitals can take advantage of the strengths and expertise of both groups to optimize cardiovascular care and patient outcomes.”

ACC is committed to maintaining the entrepreneurial and nimble spirit that has been a hallmark of MedAxiom’s success. MedAxiom will continue to operate as a wholly-owned, but separately incorporated, for-profit enterprise and will continue its current operations from its headquarters in Florida.

Addressing the increasingly complicated business and financial aspects of medicine that extend beyond clinical patient care are vital in today’s health care environment,” said Pat White, MedAxiom president. “MedAxiom is excited to join the ACC Foundation and focus on transforming cardiovascular care, together.”

Attebery will serve as the CEO of MedAxiom in addition to his role at ACC. To ensure continuity, Jennifer Linville, current MedAxiom CEO, will serve as a valuable consultant to the CEO, while Pat White, current MedAxiom president, will serve as a senior advisor.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy